Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Douglas Jabs, J. T. Rosenbaum

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalAmerican journal of ophthalmology
Volume131
Issue number5
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Behcet Syndrome
Expert Testimony
Immunosuppressive Agents
Practice Guidelines
Guidelines
Pharmaceutical Preparations
interferon alfa-2a

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{30f24e6a09e244dcaa0681dbaf99e81f,
title = "Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.",
author = "Douglas Jabs and Rosenbaum, {J. T.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0002-9394(01)00830-3",
language = "English (US)",
volume = "131",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders

T2 - recommendations of an expert panel.

AU - Jabs, Douglas

AU - Rosenbaum, J. T.

PY - 2001/1/1

Y1 - 2001/1/1

UR - http://www.scopus.com/inward/record.url?scp=18044400399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044400399&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(01)00830-3

DO - 10.1016/S0002-9394(01)00830-3

M3 - Letter

C2 - 11354352

AN - SCOPUS:18044400399

VL - 131

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -